New insider activity at BioCardia ( (BCDA) ) has taken place on March 6, 2025.
Director Simon H. Stertzer has made a significant investment in BioCardia by purchasing 38,289 shares of the company’s stock. This transaction, valued at $88,064, reflects a strong vote of confidence in the company’s future prospects.
More about BioCardia
YTD Price Performance: 11.50%
Average Trading Volume: 52,743
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.55M
Questions or Comments about the article? Write to editor@tipranks.com